These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6713784)

  • 1. Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection.
    Wills RJ; Dennis S; Spiegel HE; Gibson DM; Nadler PI
    Clin Pharmacol Ther; 1984 May; 35(5):722-7. PubMed ID: 6713784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of recombinant alpha A interferon following I.V. infusion and bolus, I.M., and P.O. administrations to African green monkeys.
    Wills RJ; Spiegel HE; Soike KF
    J Interferon Res; 1984; 4(3):399-409. PubMed ID: 6491397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant leukocyte A interferon following various routes and modes of administration to the dog.
    Gibson DM; Cotler S; Spiegel HE; Colburn WA
    J Interferon Res; 1985; 5(3):403-8. PubMed ID: 4056487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration.
    Smith RA; Norris F; Palmer D; Bernhardt L; Wills RJ
    Clin Pharmacol Ther; 1985 Jan; 37(1):85-8. PubMed ID: 3965239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous, intramuscular, and subcutaneous administration.
    Ferraiolo BL; Fuller GB; Burnett B; Chan E
    J Biol Response Mod; 1988 Apr; 7(2):115-22. PubMed ID: 3129541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous and intramuscular pharmacokinetics of recombinant leukocyte A interferon.
    Bornemann LD; Spiegel HE; Dziewanowska ZE; Krown SE; Colburn WA
    Eur J Clin Pharmacol; 1985; 28(4):469-71. PubMed ID: 4029251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of interferon alpha-2b in healthy volunteers.
    Radwanski E; Perentesis G; Jacobs S; Oden E; Affrime M; Symchowicz S; Zampaglione N
    J Clin Pharmacol; 1987; 27(5):432-5. PubMed ID: 3693589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application.
    Supersaxo A; Hein W; Gallati H; Steffen H
    Pharm Res; 1988 Aug; 5(8):472-6. PubMed ID: 3244653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of human recombinant interferon-alpha I after i.v. infusion and im injection in African green monkeys.
    Wills RJ; Soike KF
    J Interferon Res; 1988 Aug; 8(4):427-32. PubMed ID: 3171243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle.
    Kissell LW; Smith GW; Leavens TL; Baynes RE; Wu H; Riviere JE
    J Dairy Sci; 2012 Dec; 95(12):7151-7. PubMed ID: 23040013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Bioavailability of Hydroxyprogesterone Caproate Administered via Intramuscular Injection or Subcutaneous Autoinjector in Healthy Postmenopausal Women: A Randomized, Parallel Group, Open-label Study.
    Krop J; Kramer WG
    Clin Ther; 2017 Dec; 39(12):2345-2354. PubMed ID: 29191450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects.
    Lo MW; Lee FH; Schary WL; Whitney CC
    Eur J Clin Pharmacol; 1987; 33(3):297-301. PubMed ID: 3691617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of human interferons].
    Furue H; Kobayashi H; Komuro T; Kako M; Mugitani H; Fuse K; Kaise R; Nagai K; Takahashi T; Hirota F
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):935-42. PubMed ID: 6721508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy.
    Muss HB; Richards F; Homesley HD; Spurr CL; Rudnick SA; Stuart JJ; Plunkett S; Welander C; Caponera M; White DR
    Am J Clin Oncol; 1985 Apr; 8(2):97-107. PubMed ID: 3834792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Des-enkephalin-gamma-endorphin: bioavailability in rats following the subcutaneous and intramuscular route of administration.
    Verhoef JC; van den Wildenberg HM
    Regul Pept; 1986 Apr; 14(2):113-24. PubMed ID: 3715065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of human leukocyte interferon.
    Cantell K; Pyhälä L
    J Infect Dis; 1976 Jun; 133 Suppl():A6-12. PubMed ID: 932506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological effect of recombined leukocyte alpha-2-interferon in metastasizing colorectal cancers].
    Niederle N; Kurschel E; Schmidt CG
    Dtsch Med Wochenschr; 1984 May; 109(20):779-82. PubMed ID: 6723531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferons--its method of administration and adverse effect related to pharmacokinetics ].
    Furue H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic studies of the recombinant chicken interferon-α in broiler chickens.
    Zhao J; Yu HY; Zhang JL; Wang XM; Li JP; Hu T; Hu Y; Wang ML; Shen YZ; Xu JD; Han GX; Chen J
    J Vet Med Sci; 2017 Feb; 79(2):314-319. PubMed ID: 27890904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal accumulation of gentamicin in rabbits].
    Ishikawa K
    Jpn J Antibiot; 1983 Apr; 36(4):689-98. PubMed ID: 6876374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.